Prometheus Biosciences Inc Shares Close the Day 10.7% Higher - Daily Wrap
The company saw its shares close the day 10.7% higher than yesterday, with trading volume higher than its 30 day average.
Dec 21, 2021 by Kwhen Finance Editors
Prometheus Biosciences Inc (RXDX) shares closed today 10.7% higher than it did at the end of yesterday. The stock is currently up 17.9% year-to-date, up 17.9% over the past 12 months, and up 17.9% over the past five years. Today, the Dow Jones Industrial Average fell 1.2%, and the S&P 500 fell 1.1%.
Trading Activity
- Shares traded as high as $35.47 and as low as $28.74 this week.
- Shares closed 17.5% below its 52-week high and 104.8% above its 52-week low.
- Trading volume this week was 234.4% higher than the 10-day average and 560.8% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Prometheus Biosciences Inc | 10.7 | 17.9 | 17.9 | -27.5 | 79.9 |
| Dow Jones Industrial Average | -1.2 | 17.6 | 19.1 | -4.1 | 19.4 |
| S&P 500 Index | -1.1 | 24.6 | 26.2 | -3.7 | 27.2 |
| Technology Industry | 3.3 | -63.7 | -65.5 | -66.1 | 18.2 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -198.9%
- The company's stock price performance over the past 12 months beats the peer average by -176.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Prometheus Biosciences Inc | RXDX | 0 | 17.9 | 17.9 | -27.5 | 79.9 |
| Peer Avg | N/A | 60.7 | -18.1 | -23.3 | -44.6 | 15.0 |
| Agenus Inc | AGEN | 242.8 | 11.9 | 0.3 | -48.9 | 38.8 |
| Akebia Therapeutics Inc. | AKBA | 0 | -12.5 | -18.3 | -53.5 | 7.7 |
| Epizyme Inc | EPZM | 0 | -71.7 | -75.2 | -76.2 | 13.5 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: